Thyroid and cardiovascular disease: research agenda for enhancing knowledge, prevention, and treatment
AR Cappola, AS Desai, M Medici, LS Cooper, D Egan… - Circulation, 2019 - Am Heart Assoc
Thyroid hormones have long been known to have a range of effects on the cardiovascular
system. However, significant knowledge gaps exist concerning the precise molecular and …
system. However, significant knowledge gaps exist concerning the precise molecular and …
Obesity and its cardiovascular effects
C Ortega‐Loubon, M Fernández‐Molina… - Diabetes/metabolism …, 2019 - Wiley Online Library
Obesity is described in terms of body fat percentage or body mass index (BMI), despite the
fact that these measures do not give full insight about the body fat distribution. It is presently …
fact that these measures do not give full insight about the body fat distribution. It is presently …
Health status disparities by sex, race/ethnicity, and socioeconomic status in outpatients with heart failure
Objectives: This study sought to describe the health status of outpatients with heart failure
and reduced ejection fraction (HFrEF) by sex, race/ethnicity, and socioeconomic status …
and reduced ejection fraction (HFrEF) by sex, race/ethnicity, and socioeconomic status …
Beta-blockers in heart failure with preserved ejection fraction: a meta-analysis
Beta-blockers are established drugs in heart failure with reduced ejection fraction, but their
role in heart failure with preserved ejection fraction (HFpEF) is not established. Hence, we …
role in heart failure with preserved ejection fraction (HFpEF) is not established. Hence, we …
[HTML][HTML] Cardiac contractility modulation: a novel approach for the treatment of heart failure
F Abi-Samra, D Gutterman - Heart failure reviews, 2016 - Springer
Heart failure is a major health problem worldwide and, despite effective therapies, is
expected to grow by almost 50% over the next 15 years. Five-year mortality remains high at …
expected to grow by almost 50% over the next 15 years. Five-year mortality remains high at …
Left ventricular assist devices: a primer for the general cardiologist
SP Chaudhry, AD DeVore, H Vidula… - Journal of the …, 2022 - Am Heart Assoc
Durable implantable left ventricular assist devices (LVADs) have been shown to improve
survival and quality of life for patients with stage D heart failure. Even though LVADs remain …
survival and quality of life for patients with stage D heart failure. Even though LVADs remain …
Survival and risk of recurrence of takotsubo syndrome
C Lau, S Chiu, R Nayak, B Lin, MS Lee - Heart, 2021 - heart.bmj.com
Objective The goal of this study is to evaluate the long-term outcomes of patients with
takotsubo syndrome and assess factors associated with death or recurrence. Methods This …
takotsubo syndrome and assess factors associated with death or recurrence. Methods This …
[HTML][HTML] Korean guidelines for diagnosis and management of chronic heart failure
MS Kim, JH Lee, EJ Kim, DG Park… - Korean Circulation …, 2017 - synapse.koreamed.org
The prevalence of heart failure (HF) is skyrocketing worldwide, and is closely associated
with serious morbidity and mortality. In particular, HF is one of the main causes for the …
with serious morbidity and mortality. In particular, HF is one of the main causes for the …
CXCL10 is a circulating inflammatory marker in patients with advanced heart failure: a pilot study
Chemokines are involved in the remodeling of the heart; however, their significance as
biomarkers in heart failure is unknown. We observed that circulating CXCR3 receptor …
biomarkers in heart failure is unknown. We observed that circulating CXCR3 receptor …
Type 2 diabetes and heart failure: challenges and solutions
MC Thomas - Current cardiology reviews, 2016 - ingentaconnect.com
Increasing numbers of older patients with type 2 diabetes, and their improved survival from
cardiovascular events is seeing a massive increase in patients with both diabetes and heart …
cardiovascular events is seeing a massive increase in patients with both diabetes and heart …